Why the study?
Does captopril reduce urinary protein excretion in hypertensive patients with renal diseases compared to a calcium antagonist?
Does captopril reduce urinary protein excretion in hypertensive patients with renal diseases compared to a calcium antagonist?
Captopril significantly reduces proteinuria in hypertensive patients with renal disease independent of its antihypertensive effect, unlike calcium channel blockers.
Answers are grounded in this paper and cite their sources.
Suggests ACEIs reduce proteinuria beyond BP effects in renal disease; leaves open outcome benefits versus calcium antagonists.
A crossover study was planned in order to compare the effects of captopril and slow channel calcium entry blocker (Ca antagonist) on urinary protein excretion in 7 hypertensive patients with renal diseases, including 4 with IgA nephropathy, 2 with lupus nephritis and 1 with benign nephrosclerosis. Captopril decreased urinary protein excretion by 52% without any change in creatinine clearance, while Ca antagonist was having a slight effect on proteinuria even though the drug showed an equivalent antihypertensive effect as captopril. These results suggest that the attenuation of proteinuria induced by captopril may be related to an inhibition of angiotensin II formation and/or a direct action of this drug on protein permeability of glomerular basement membrane.
No takes yet. Share an insight, caveat, or question.
Ikeda et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: